The Short Version
The claim is broadly supported when read as an annual statement. International and national ART registries show millions of treatment cycles each year worldwide, making millions of patients plausible, and annual live-birth success rates are generally well under 50%. The main caveat is that global data usually count cycles rather than unique people, and cumulative success after multiple cycles can be higher than annual results.